If you have spent any time reading ingredient labels or browsing beauty forums, you have probably absorbed the idea that parabens are something to avoid. The word has become shorthand for "toxic." Entire product lines are marketed on the promise of being "paraben-free," and it is easy to assume that if so many brands are removing them, there must be a good reason.
The real story is more complicated. Parabens have been used as preservatives for nearly a century, they appear in everything from shampoo to salad dressing, and the scientific evidence behind the fear is surprisingly thin. That does not mean there are no legitimate questions. It means the conversation has been hijacked by marketing, media headlines, and a single flawed study from 2004.
We want to walk you through what the research actually says, what regulators around the world have concluded, and where honest caution is still warranted. No demonizing, no dismissing. Just the evidence.
What Parabens Actually Are
Parabens are a family of synthetic preservatives derived from para-hydroxybenzoic acid, a compound that also occurs naturally in blueberries, carrots, and olives. The most commonly used parabens in cosmetics are methylparaben, ethylparaben, propylparaben, and butylparaben.
They were first introduced in the 1920s and quickly became the most widely used preservatives in the world, appearing in over 85% of cosmetic products. The reason is straightforward: they are effective against a broad range of bacteria, yeast, and mould at very low concentrations (typically 0.1% to 0.3%), they work well across different product types, they are inexpensive, and they have an extremely low rate of allergic reactions.
The American Contact Dermatitis Society named parabens the "Non-Allergen of the Year" in 2019, noting a sensitization rate of just 0.5% to 1.4% in patch-tested individuals. That is the lowest of any preservative class on the market.
The Study That Changed Everything
In 2004, Dr. Philippa Darbre of the University of Reading published a study that reported finding traces of parabens in 20 human breast tumour samples. The paper received enormous media coverage. Advocacy groups seized on it as proof that parabens in deodorants and cosmetics were causing breast cancer. The panic has never fully subsided.
But the study had serious problems that were widely underreported.
There was no control group. The researchers measured parabens in cancerous tissue but never compared their findings with healthy, non-cancerous tissue. Since parabens are used in foods, cosmetics, and pharmaceuticals and are detectable in 96% to 100% of the general population, finding them in any tissue sample tells you very little.
There is more. The blank samples in the experiment, which contained no tissue at all, also showed paraben contamination. Some of those blanks actually contained higher levels of parabens than the tumour samples themselves. This raised the possibility that none of the parabens measured actually came from the tumours.
The quantities detected were in nanograms per gram, roughly equivalent to half a teaspoon dissolved in an Olympic-sized swimming pool. The study did not claim parabens caused the cancers. Six months after publication, the authors themselves clarified: "Nowhere in the manuscript was any claim made that the presence of parabens had caused the breast cancer, indeed the measurement of a compound in a tissue cannot provide evidence of causality."
In 2012, a separate study found higher paraben levels in non-cancerous breast tissue than the Darbre study had found in tumours, further undermining the original implication.
The European Commission's Scientific Committee on Consumer Safety (SCCS) reviewed the Darbre study and identified major deficiencies in the study design, including the lack of control tissue and the contaminated blank samples. They concluded there was "no evidence of a demonstrable risk for the development of breast cancer caused by the use of underarm cosmetics."
The Endocrine Disruption Question
This is where the science gets genuinely interesting, and where we owe you the full truth.
Parabens do have weak estrogenic activity. They can bind to estrogen receptors and mimic the effects of estrogen at a molecular level. This was first demonstrated by Routledge et al. in 1998, and it has been confirmed in numerous studies since. This is a real, measurable property, not a myth.
The critical question is: how weak?
Butylparaben, the most potent paraben tested, was 10,000 times weaker than estradiol in lab cell tests and 100,000 times weaker in live rats. Methylparaben, the most commonly used paraben, was 2,500,000 times weaker and completely inactive in rats.
Routledge et al., 1998; LabMuffin Beauty Science
A 2023 comparative study published in Toxicological Research confirmed these proportions, finding that the estrogenic transcriptional activity of parabens ranged from approximately 130,000-fold to 5,300,000-fold weaker than estradiol, depending on the paraben type. Methylparaben showed no transcriptional activity at all in their assay.
To put this in dietary context: the phytoestrogens naturally present in soybeans, flaxseed, and chickpeas are approximately 200 times more potent than propylparaben. Your body's own natural estrogen production dwarfs anything parabens could contribute through skin absorption.
A study in which 2% butylparaben cream (far exceeding the typical cosmetic concentration of 0.1% to 0.3%) was applied to participants' entire bodies for a week found no measurable effect on reproductive or thyroid hormones.
But Newer Research Has Raised Legitimate Concerns
We would not be honest if we stopped there. The science has continued to evolve, and some findings merit attention even if they do not justify the panic.
A 2017 study in the International Journal of Molecular Sciences identified a mechanism by which parabens can interfere with local estrogen metabolism. Certain parabens (particularly ethylparaben and heptylparaben) inhibit an enzyme called 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD2), which normally inactivates estrogen in tissues. By blocking this enzyme, parabens could theoretically increase local estrogen concentrations in ways that go beyond their direct receptor binding.
A 2022 review in the International Journal of Environmental Research and Public Health noted that parabens can also crosstalk with the HER2 signaling pathway and potentially increase pro-oncogenic gene expression in certain breast cancer cell lines in vitro.
A 2016 study in Scientific Reports found that methylparaben and ethylparaben showed estrogenic activity in rats at doses that produced urinary concentrations similar to those measured in heavily exposed human populations. The authors suggested the acceptable daily intake set by regulators may be too high for certain subpopulations.
Parabens do have real endocrine activity. The longer the alkyl chain (moving from methyl to butyl), the stronger the activity. But at the concentrations used in cosmetics, these effects are orders of magnitude weaker than your body's own hormones and the phytoestrogens you consume in food every day. The question is whether chronic, low-level, cumulative exposure through multiple product sources might still matter over a lifetime. We do not yet have a definitive answer to that.
What Regulators Actually Say
Every major regulatory body that has reviewed the evidence on parabens has reached broadly similar conclusions:
The U.S. Food and Drug Administration states: "At this time, we do not have information showing that parabens as they are used in cosmetics have an effect on human health."
The EU Scientific Committee on Consumer Safety (SCCS) concluded in 2023 that methylparaben is safe at concentrations up to 0.4% (the standard cosmetic limit). For propylparaben, the SCCS set a safe limit of 0.14% in 2021, noting that "the available data provide some indications for potential endocrine effects," but "the current level of evidence is not sufficient to regard it as an endocrine disrupting substance."
The Cosmetic Ingredient Review (CIR) panel, which has reviewed parabens repeatedly since 1984, reaffirmed in 2012 that parabens are safe at current use levels. Their safety margin calculations showed exposure from cosmetics is thousands of times below levels that produced no adverse effects in animal studies.
Organisations including the National Cancer Institute, Health Canada, Cancer Council Australia, and the Centers for Disease Control and Prevention have all stated that current paraben use is not linked to cancer.
The EU has banned isopropylparaben, isobutylparaben, pentylparaben, phenylparaben, and benzylparaben, but not because of evidence of harm. The ban was due to insufficient safety data. Methylparaben and ethylparaben limits have remained unchanged since 2000.
Not All Parabens Are Equal
One of the most misleading aspects of the "paraben-free" movement is that it treats all parabens as a single entity. They are not.
Methylparaben and ethylparaben are the shortest-chain parabens. They have the weakest estrogenic activity, are metabolised most quickly by the body, and have the strongest safety record. Neither the EU nor any other regulatory body has expressed significant concern about them at standard cosmetic concentrations.
Propylparaben and butylparaben are longer-chain parabens with measurably stronger (though still weak) estrogenic activity. The EU has restricted their combined use to 0.14% and banned them from leave-on products for the nappy area of children under three. These restrictions are precautionary, not based on confirmed harm, but they reflect a reasonable "better safe than sorry" position given the data gaps.
Saying "I avoid parabens" is like saying "I avoid all medications." The specifics matter enormously.
The Problem with Removing Parabens
Here is the part that rarely gets discussed: what happens when you take parabens out of products?
An unpreserved water-based cosmetic is a growth medium for bacteria, yeast, and mould. Products used near the eyes can cause serious infections and even blindness if contaminated. Every cosmetic that contains water needs an effective preservative system. The question is not whether to preserve, but how.
Paraben replacements are not necessarily safer. Many are less effective, requiring higher concentrations, and some carry significantly higher allergy risks. Here is how parabens compare to common alternatives in patch-test allergy rates:
Parabens: 0.5 to 1.7%. Formaldehyde releasers (quaternium-15): up to 9%. Isothiazolinones (MI/MCI): 2.3 to 2.9%. Diazolidinyl urea: 2.7 to 3.7%. These are rates among people specifically being tested for contact allergies. In the general population, paraben allergy is even rarer.
"Natural" preservatives like essential oils and organic acids are less effective and often more irritating and allergenic. Many "clean" brands that drop parabens end up using preservation systems with far less safety data behind them.
As Michelle Wong (PhD, LabMuffin Beauty Science) puts it: parabens have been used for almost 100 years by billions of people, with extensive testing. Newer preservatives have not been used for as long and have not undergone as much scrutiny. Their long-term health risks are unknown and could be far worse.
Where Dear Care Stands
Our products use Sodium Benzoate as a preservative. We chose it because it is well-studied, effective at the concentrations we use, and appropriate for our formulations. We do not use parabens, not because we believe they are dangerous, but because our specific formulations work well with the preservation systems we have selected.
We will never tell you that our products are better because they are "paraben-free." That framing implies parabens are harmful, and the evidence does not support that claim at standard cosmetic concentrations. If a product you love contains methylparaben or ethylparaben, the science says you do not need to be afraid of it.
What we will tell you is exactly what is in our products, why each ingredient is there, and what the evidence says about it. Our Certificate of Analysis is available on request.
What the Evidence Supports
After reviewing the research, here is what we think a fair summary looks like:
Methylparaben and ethylparaben have the strongest safety record of any preservatives in cosmetic history. At standard use levels, they pose no demonstrated risk to human health. Every major regulatory body agrees on this.
Propylparaben and butylparaben warrant more caution. Their estrogenic activity, while still very weak, is measurably stronger, and the EU has tightened limits as a precaution. Avoiding excessive exposure to these specific parabens, especially in products for infants, is a reasonable position supported by the evidence.
There is no direct evidence that parabens in cosmetics have ever caused cancer, reproductive harm, or clinically meaningful endocrine disruption in humans. After nearly a century of use by billions of people, no study has established that link.
Legitimate scientific questions remain about cumulative, low-dose, long-term exposure from multiple sources. These questions deserve continued research, not premature conclusions in either direction.
The beauty industry has profited enormously from paraben fear. We would rather give you the information to make your own decision than exploit your uncertainty for a sale.
